(Q39173896)

9 September 2017

title

Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial (English)

1 reference

9 September 2017

0 references

Clio Dessinioti

1

1 reference

9 September 2017

Michaela Plaka

series ordinal

2

1 reference

9 September 2017

Alexander J Stratigos

series ordinal

3

1 reference

9 September 2017

language of work or name

English

0 references

publication date

1 May 2014

1 reference

9 September 2017

1 reference

9 September 2017

volume

10

1 reference

9 September 2017

issue

6

1 reference

9 September 2017

page(s)

927-936

1 reference

A systematic review of worldwide incidence of nonmelanoma skin cancer

9 September 2017

cites work

1 reference

Basal cell carcinoma: what's new under the sun.

21 January 2018

1 reference

Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

21 January 2018

1 reference

The molecular genetics underlying basal cell carcinoma pathogenesis and links to targeted therapeutics

21 January 2018

1 reference

Vismodegib: a promising drug in the treatment of basal cell carcinomas

21 January 2018

1 reference

Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas

21 January 2018

1 reference

The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas

21 January 2018

1 reference

Activating Smoothened mutations in sporadic basal-cell carcinoma

21 January 2018

1 reference

Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors.

21 January 2018

1 reference

Pharmacokinetic dose-scheduling study of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors

21 January 2018

1 reference

Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma

21 January 2018

1 reference

Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fat.

21 January 2018

1 reference

Initial assessment of tumor regrowth after vismodegib in advanced Basal cell carcinoma

21 January 2018

1 reference

Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449

21 January 2018

1 reference

Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.

21 January 2018

1 reference

Emergence of a squamous cell carcinoma phenotype following treatment of metastatic basal cell carcinoma with vismodegib

21 January 2018

1 reference

Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FON.14.50

1 reference

9 September 2017

1 reference